文献速递造血干细胞移植与细胞治疗

基于功能距离的无关供者造血干细胞移植中非允许性HLA-DPB1错配的计算机预测

In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.
PubMed 文献 · Blood Adv · 2018-01-01

该研究在2730例8/8 HLA相合的无关供者造血干细胞移植中,比较了TCE-X与TCE-FD两种模型定义的非允许性DPB1错配与临床结局的关联。两模型一致率为92.3%,非允许性错配均与总生存降低、移植相关死亡率增加及急慢性GVHD风险升高相关。基于功能距离评分的计算机预测对任何已知外显子2序列的DPB1等位基因可行。

要点

  • TCE-X与TCE-FD模型对DPB1错配分类的一致率为92.3%。
  • 两模型定义的非允许性错配均与总生存降低和移植相关死亡率增加相关。
  • 非允许性错配还与急性和慢性GVHD风险升高相关。

核心结论

  • 基于实验建立的功能距离评分,对任何已知外显子2序列的DPB1等位基因进行非允许性错配的计算机预测是可行的,且与主要移植结局显著相关。

研究设计与样本

  • 研究纳入1999年至2011年间接受8/8 HLA相合无关供者造血干细胞移植的急性白血病、骨髓增生异常综合征和慢性髓性白血病患者2730例,比较TCE-X与TCE-FD两种模型定义的非允许性DPB1错配与临床结局的关联。

主要发现

  • 两模型一致率为92.3%,差异主要来自DPB1*06:01和DPB1*19:01的赋值不同。
  • TCE-X定义的非允许性错配与总生存降低(HR 1.15,P < .006)、移植相关死亡率增加(HR 1.31,P < .001)、急性GVHD(HR 1.16,P < .02)和慢性GVHD(HR 1.20,P < .003)风险升高相关。
  • TCE-FD定义的非允许性错配与总生存降低(HR 1.12,P < .03)、移植相关死亡率增加(HR 1.26,P < .001)、急性GVHD(HR 1.22,P < .001)和慢性GVHD(HR 1.22,P < .001)风险升高相关。

临床怎么用

  • 作者认为该原理验证性观察为开发造血干细胞移植中的HLA风险预测模型开辟了新途径,并对无关供者搜索具有实际意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In silico prediction of high-risk donor-recipient HLA mismatches after unrelated donor (UD) hematopoietic cell transplantation (HCT) is an attractive, yet elusive, objective. Nonpermissive T-cell epitope (TCE) group mismatches were defined by alloreactive T-cell cross-reactivity for 52/80 HLA-DPB1 alleles (TCE-X). More recently, a numerical functional distance (FD) scoring system for in silico prediction of TCE groups based on the median impact of exon 2-encoded amino acid polymorphism on T-cell alloreactivity was developed for all DPB1 alleles (TCE-FD), including the 28/80 common alleles not assigned by TCE-X. We compared clinical outcome associations of nonpermissive DPB1 mismatches defined by TCE-X or TCE-FD in 8/8 HLA-matched UD-HCT for acute leukemia, myelodysplastic syndrome, and chronic myelogenous leukemia between 1999 and 2011 (N = 2730). Concordance between the 2 models was 92.3%, with most differences arising from DPB1*06:01 and DPB1*19:01 being differently assigned by TCE-X and TCE-FD. In both models, nonpermissive mismatches were associated with reduced overall survival (hazard ratio [HR], 1.15, P < .006 and HR, 1.12, P < .03), increased transplant-related mortality (HR, 1.31, P < .001 and HR, 1.26, P < .001) as well as acute (HR, 1.16, P < .02 and HR, 1.22, P < .001) and chronic (HR, 1.20, P < .003 and HR, 1.22, P < .001) graft-versus-host disease (GVHD). We show that in silico prediction of nonpermissive DPB1 mismatches significantly associated with major transplant outcomes is feasible for any DPB1 allele with known exon 2 sequence based on experimentally elaborated FD scores. This proof-of-principle observation opens new avenues for developing HLA risk-prediction models in HCT and has practical implications for UD searches.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Arrieta-Bolaños E, Crivello P, Shaw BE, et al. In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance. Blood Adv. 2018. PMID: 30042143. doi:10.1182/bloodadvances.2018019620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。